Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) EBIT Margin (2021)

Historic EBIT Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to 63.06%.

  • Atea Pharmaceuticals' EBIT Margin changed N/A to 63.06% in Q4 2021 from the same period last year, while for Sep 2022 it was 15.83%, marking a year-over-year decrease of 79400.0%. This contributed to the annual value of 39.38% for FY2021, which is 620600.0% up from last year.
  • According to the latest figures from Q4 2021, Atea Pharmaceuticals' EBIT Margin is 63.06%.
  • Atea Pharmaceuticals' 5-year EBIT Margin high stood at 63.06% for Q4 2021, and its period low was 67.5% during Q3 2021.